Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Wadleigh M, Deangelo DJ, Griffin JD, Stone RM . After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies. Blood 2005; 105: 22–30 (Epub 2004 September 09).

    Article  CAS  Google Scholar 

  2. Hannemann JR, McManus DM, Kabarowski JH, Wiedemann LM . Haemopoietic transformation by the TEL/ABL oncogene. Br J Haematol 1998; 102: 475–485.

    Article  CAS  Google Scholar 

  3. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F et al. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer 1997; 20: 299–304.

    Article  CAS  Google Scholar 

  4. Barbouti A, Ahlgren T, Johansson B, Hoglund M, Lassen C, Turesson I et al. Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. Br J Haematol 2003; 122: 85–93.

    Article  CAS  Google Scholar 

  5. La Starza R, Trubia M, Testoni N, Ottaviani E, Belloni E, Crescenzi B et al. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia. Haematologica 2002; 87: 789–794.

    PubMed  Google Scholar 

  6. Keung YK, Beaty M, Steward W, Jackle B, Pettnati M . Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature. Cancer Genet Cytogenet 2002; 138: 139–142.

    Article  CAS  Google Scholar 

  7. Million RP, Aster J, Gilliland DG, Van Etten RA . The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood 2002; 99: 4568–4577.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Heike Huxol for the excellent technical assistance for the RT-PCR. We are also grateful to Sandrine Bougeon, Ornella Bruzzese, Danielle Ahmad and Christelle Saporita for expert technical assistance for the cytogenetic preparations, Anne-Claude Gaide and Marianne Wicht for the determination of the constitutional karyotype and P Marynen and A Hagemeijer-Hausmann, Leuven, for providing us with the cosmid probes. We also would like to thank Regine Landmann for carefully reading the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Meyer-Monard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer-Monard, S., Mühlematter, D., Streit, A. et al. Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript. Leukemia 19, 1096–1099 (2005). https://doi.org/10.1038/sj.leu.2403697

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403697

This article is cited by

Search

Quick links